C-Jun-amino-terminal kinase-interacting protein 2 (683-692)

C-Jun-amino-terminal kinase-interacting protein 2 (683-692) is a synthetic peptide fragment derived from the C-terminal region of the JIP2 scaffold protein. As a member of the JIP (JNK-interacting protein) family, JIP2 plays a pivotal role in modulating the c-Jun N-terminal kinase (JNK) signaling pathway, which is involved in diverse cellular processes such as stress response, neuronal development, and apoptosis. The 683-692 sequence represents a specific segment of JIP2 that may be critical for protein-protein interactions, subcellular localization, or regulatory functions within the MAPK signaling cascade. Researchers employ this peptide to dissect the molecular mechanisms underlying JNK pathway modulation, providing valuable insights into signal transduction and cellular regulation.

Signal Transduction Research: The JIP2 (683-692) peptide is frequently utilized in studies examining the assembly and regulation of MAPK signaling complexes. By serving as a defined molecular probe, it allows researchers to investigate how specific regions of scaffold proteins influence the recruitment and organization of kinases and downstream effectors. Experiments using this peptide can reveal the contribution of the C-terminal domain to JNK pathway specificity, aiding in the delineation of scaffold-mediated signal propagation and fidelity.

Protein-Protein Interaction Mapping: As a discrete peptide segment, JIP2 (683-692) is valuable in mapping direct binding interfaces between scaffold proteins and their interacting partners. In vitro binding assays, pull-down experiments, or peptide microarrays employing this sequence can help identify novel interaction motifs and characterize the affinity and selectivity of JIP2 for associated kinases or regulatory proteins. Such studies are instrumental in defining the structural determinants of scaffold function and in elucidating the molecular basis of signal modulation.

Peptide Inhibitor Development: The defined sequence of the JIP2 (683-692) peptide enables its use as a template or competitor in the design and optimization of peptide-based inhibitors targeting the JNK signaling pathway. By mimicking key interaction domains, it can serve as a lead structure for developing molecules that disrupt pathological protein-protein interactions within the MAPK cascade. This approach supports the rational design of research tools for probing pathway inhibition and for validating molecular targets in cell-based assays.

Cellular Localization Studies: Incorporation of the JIP2 (683-692) peptide into fluorescence-tagging or peptide transduction protocols facilitates the investigation of scaffold protein localization within cells. Researchers can track the intracellular distribution of this peptide segment to assess its role in subcellular targeting, compartmentalization, or trafficking of JIP2 and associated kinases. Such studies provide important context for understanding the spatial dynamics of signaling complexes in neuronal and non-neuronal systems.

Phosphorylation and Post-Translational Modification Analysis: The JIP2 (683-692) peptide can serve as a substrate in kinase assays or be employed to study potential phosphorylation sites within the C-terminal region of JIP2. By analyzing the modification patterns and kinetics of this segment, scientists can gain insight into regulatory mechanisms that modulate scaffold protein activity and JNK pathway responsiveness. These applications are particularly relevant for clarifying the interplay between post-translational modifications and scaffold-mediated signaling in diverse biological contexts.

1. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment

2. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines

3. Myotropic activity of allatostatins in tenebrionid beetles

4. Olfactory receptor based piezoelectric biosensors for detection of alcohols related to food safety applications

5. Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction